Merck KGaA Nudges Outlook Higher as New CEO Takes Charge

Merck KGaA raised its full-year outlook slightly due to stronger-than-expected momentum in parts of its life-science division, offering an early boost for new Chief Executive Officer Kai Beckmann.

The German group now expects full-year adjusted earnings before interest, tax, depreciation and amortization of between €5.7 billion ($6.7 billion) and €6.1 billion, up from a previous peak of €6 billion. That compares with last year’s €6.1 billion figure.